NewSquare Capital’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MG
WBG
PVH
HF
NewSquare Capital's XPH Position: Q3 2015 in Review
NewSquare Capital sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 36 shares — an estimated $2K sold.
NewSquare Capital first reported a position in XPH in Q3 2014 and held it in 4 quarters. The position peaked at $10K in Q3 2014. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.
- NewSquare Capital reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
- NewSquare Capital sold 36 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $2K.
- NewSquare Capital first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2014 and held it in 4 quarters.
- NewSquare Capital's State Street SPDR S&P Pharmaceuticals ETF position peaked at $10K in Q3 2014.
- 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.
Based on NewSquare Capital's 13F filing for Q3 2015, filed 20 Oct 2015.